Target intelligence / Profile preview

SINHCAF pseudogene 2 (SINHCAFP2)

Target
SINHCAFP2
Molecular classification
Other (pseudogene)
01

Overview

SINHCAF pseudogene 2 (SINHCAFP2) is a *pseudogene* and, by definition, is a DNA sequence in the human genome that resembles the parental SINHCAF gene but does not encode a functional protein due to disabling mutations or deletions[1][3][5][7][9]. Pseudogenes arise from gene duplication or retrotransposition events and are usually nonfunctional, lacking regulatory elements or containing mutations such as frameshifts or premature stop codons. Unlike the parental SINHCAF gene (which encodes a subunit of the Sin3A histone deacetylase complex involved in transcriptional repression and epigenetic regulation[2][4]), SINHCAFP2 does not produce a functional product and is not considered a therapeutic target. Pseudogenes may occasionally have regulatory roles in gene expression, but there is no evidence supporting such a role for SINHCAFP2[3][7][9]. It is not a drug target, does not have known disease associations, and is not used as a biomarker or for patient selection. Summary of key issues: - SINHCAFP2 is a *pseudogene*, not a protein-coding gene or a classical drug target[1][5][7][9]. - There is no evidence it is therapeutically actionable. - There is no established physiological or disease role, nor are there known drug interactions for this locus. If you intended to refer to the functional SINHCAF gene (not its pseudogene), please specify, as that gene encodes a protein involved in epigenetic and transcriptional regulation[2][4].

02

Mechanism of action

none

03

Biological functions

none (no known functional protein product)
04

Disease associations

none established; pseudogenes are generally not direct disease drivers

Beyond the preview

Go deeper on SINHCAF pseudogene 2 (SINHCAFP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SINHCAF pseudogene 2 (SINHCAFP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call